GFS Advisors’s Teladoc Health TDOC Stock Holding History

GFS Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,840	Closed	-$368K	–	142
2020 Q4	$368K	Buy	+1,840	New	+$374K	0.1%	107

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

DVF

Discovery Value Fund Singapore $39.8M AUM 27.89% 1-Year Est. Return

GFS Advisors's TDOC Position: Q1 2021 in Review

GFS Advisors sold out of Teladoc Health (TDOC) in Q1 2021, closing a stake of 1,840 shares — an estimated $368K sold.

GFS Advisors first reported a position in TDOC in Q4 2020 and held it in 1 quarter. The position peaked at $368K in Q4 2020. 890 funds tracked by Wall St. Rank hold TDOC as of Q1 2021.

GFS Advisors reported no remaining Teladoc Health position as of Q1 2021 after selling out during the quarter.
GFS Advisors sold 1,840 Teladoc Health shares in Q1 2021, an estimated $368K.
GFS Advisors first reported a position in Teladoc Health in Q4 2020 and held it in 1 quarter.
GFS Advisors's Teladoc Health position peaked at $368K in Q4 2020.
890 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2021.

Based on GFS Advisors's 13F filing for Q1 2021, filed 3 May 2021.